Padcev 30 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM0PU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,658
Award facts
- Contract value 100% obligated
- $12,658.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,658.40 for 30 mg vials of Padcev on December 15, 2025, with completion targeted for January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal procurement presence primarily through its DLA partnerships. The company's contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems. This delivery order for Padcev, a specialized oncology medication, reflects the contractor's critical role in supplying therapeutic pharmaceuticals to military medical procurement needs. The DLA's planned transition to Pharmaceutical Prime Vendor Global Program Generation V contracts, which will involve multiple regional awards, underscores the continued strategic importance of vendors like AmerisourceBergen in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM0PU?
SPE2DR26FM0PU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FM0PU worth?
The government has obligated $12,658 on SPE2DR26FM0PU.
Is contract SPE2DR26FM0PU an order under another contract?
Yes. SPE2DR26FM0PU is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0PU competed?
The extent of competition for SPE2DR26FM0PU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award